Navigation Links
Pitt receives $13.4 million NIH grant to create virtual models for epidemics
Date:7/31/2009

PITTSBURGH, July 31 As the world prepares for a probable resurgence of H1N1 in the coming months, University of Pittsburgh researchers are controlling the spread of infectious diseases virtually with a $13.4 million National Institutes of Health (NIH) grant to establish a Center of Excellence in Modeling of Infectious Diseases. The five-year grant, part of the NIH's Modeling of Infectious Disease Agent Study (MIDAS) program, funds the development and testing of computer simulations that will ultimately enable public health officials and policymakers to evaluate intervention strategies to contain infectious disease outbreaks.

The center, led by Donald S. Burke, M.D., dean of the University of Pittsburgh Graduate School of Public Health, uses census and other data sets to build simulations of individuals as they move about and interact with one another through schools, workplaces, households and communities. By modeling their contacts, the Pitt team is working to determine the likelihood a person will spread the disease to others, and to evaluate which interventions might be the most effective such as school closings, travel restrictions, hand washing, vaccines or a combination of these techniques.

"Stopping the spread of infectious diseases remains one of the most significant public health challenges of our time," Dr. Burke said. "It is difficult to predict how infectious disease control strategies will work because the spread of infection through a population depends on a multitude of factors. But by testing interventions 'in silico' before an epidemic occurs, we can work through which strategies will be the most likely to succeed in preventing illness and death."

"The MIDAS center at the University of Pittsburgh brings together an exceptionally talented group of investigators," said Irene Eckstrand, Ph.D., who co-directs the MIDAS program at the National Institute of General Medical Sciences, part of the NIH. "Their diverse areas of expertise will be a huge asset in building robust models that provide timely and practical information that public health policymakers need. The center also will serve as a hub for training the next generation of infectious disease modelers."

Projects funded by the grant include: developing statistical tools to define the features of a pathogen and its spread through a population; identifying personal health behaviors and the social factors that influence decision-making related to prevention; tracking the evolution of infectious diseases over time; studying the impact of the seasons and variations in climate on infectious disease trajectories; putting a system in place to effectively implement an intervention; and providing new computational tools to local health officials.

These projects build on large-scale simulations previously developed by Dr. Burke and his colleagues to control a threatening avian influenza pandemic. These models were influential in forming the World Health Organization's decision about the size of antiviral medicine stockpiles needed to quash a possible avian flu outbreak, and in shaping U.S. Department of Health and Human Services' policies about the impact of "social distancing" during an influenza epidemic.


'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom
2. TriReme Medical, Inc. Receives CE Marking for Glider(TM) PTCA Dilatation Catheter
3. New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA
4. GenVec Receives Grant for Malaria Vaccine Program
5. Olympus Managed Health Care Receives Third Party Administrative License in State of Florida
6. Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award
7. Lilly Receives Award From National Medical Association
8. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
9. Assara Laser Hair Removal Centers (New York, NY) Receives 2008 New York Award for Cosmetology & Personal Hygiene Salons by the U.S.C.A.
10. Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution
11. Case Western Reserve University receives $3.7M NIH grant to study autonomic nervous system link to painful bladder syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: